Skip to main content

Table 3 Results of literature review

From: Pulmonary sclerosing pneumocytoma: clinical features and prognosis

Author

Years

Patients

Female

Age

Size, cm

Lobe locationa

Extent of resection

Survival status

     

RUL

RML

RLL

LUL

LLL

Lobectomy

Sub-lobectomy

Lost to follow-up

Dead

Alive

K.W. Chan [20]

1982

14

14

50 (16.21)

2.33 (0.64)

0

2

5

4

1

9

1

6

1

7

A.S Fassina [21]

1986

6

3

59 (9.72)

1.83 (0.59)

     

4

2

1

 

5

N.P Ohori [22]

1991

14

14

45 (14.65)

        

3

3

8

A.C. Chan [23]

2000

1 6

15

52 (14.13)

2.39 (1.65)

1

5

4

0

6

     

J.E. Nam [24]

2002

2

2

50 (16.26)

2.25 (1.06)

0

0

0

0

2

     

M.C. Aubry [25]

2002

16

16

50 (12.65)

2.96 (2.35)

     

1

10

1

1

14

Y.C. Cheung [26]

2003

6

5

35 (14.58)

      

6

2

   

K. Yamazaki [27]

2004

7

7

54 (14.30)

4.50 (3.22)

          

S.D. Sak [28]

2007

26

16

53 (9.76)

2.08 (1.31)

5

2

3

2

14

     

G. Sartori [29]

2007

11

10

47 (11.00)

3.09 (0.80)

1

2

0

4

4

5

6

  

11

S. Islam [30]

2009

6

3

56 (9.75)

1.92 (0.59)

     

1

1

   

K.H. Lin [31]

2011

6

5

50 (11.29)

2.87 (1.55)

0

1

1

1

3

     

Q.B. Wang [32]

2011

16

14

53 (11.66)

 

1

9

4

2

1

     

Lee, E [33].

2013

26

23

44 (11.47)

2.47 (1.26)

2

6

6

2

8

     

C.Y. Wu [34]

2016

14

14

53 (15.12)

2.26 (1.41)

2

2

2

3

5

     

A. Lovrenski [35]

2019

6

5

51 (9.00)

1.75 (0.50)

0

0

1

2

3

    

6

J. Xu [36]

2019

22

12

54 (12.76)

2.59 (1.38)

          

Q. Gao [37]

2020

32

23

41 (18.57)

4.77 (3.11)

4

1

9

6

12

     

Overall

 

246

201

49 (14.51)

2.75 (1.95)

16

30

35

26

59

26

22

11

5

51

Median (range)

   

51(10-78)

2.20 (0.50-1.20)

          
  1. The data was presented as mean (SD) or median (range)
  2. a LUL left upper lobe, LLL left lower lobe, RLL right lower lobe, RML, right middle lobe, RLL right lower lobe